1-3 of 3
Liping Xie
Close
Sort by
Journal Articles

Safety and Efficacy of the Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with WaldenstrC6m Macroglobulinemia from a Phase 2 Trial

Gang An, MD PhD, Daobin Zhou, MD PhD, Weili Zhao, MD PhD, Keshu Zhou, MD PhD, Jianyong Li, MD PhD, Jianfeng Zhou, MD PhD, Liping Xie, MD PhD, Jie Jin, MD PhD, Liye Zhong, MD PhD, Lingzhi Yan, MD PhD, Haiyi Guo, MD, Chenmu Du, MD, Jane Huang, MD, William Novotny, MD, Jinhua Zhong, PhD, Lugui Qiu, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 42–43.
https://doi.org/10.1182/blood-2020-136783
Published: 2020
Journal Articles

Nivolumab treatment of relapsed/refractory Epstein-Barr virus–associated hemophagocytic lymphohistiocytosis in adults

Clinical Trials & Observations
Pengpeng Liu, Xiangyu Pan, Chong Chen, Ting Niu, Xiao Shuai, Jian Wang, Xuelan Chen, Jiazhuo Liu, Yong Guo, Liping Xie, Yu Wu, Yu Liu, Ting Liu
Journal: Blood
Blood (2020) 135 (11): 826–833.
https://doi.org/10.1182/blood.2019003886
Published: 2020
Includes: Supplemental data
Journal Articles

Retrospective Treatment Analysis of a Series of 104 Patients with Adult Onset Hemophagocytic Lymphohistiocytosis in a Single Institution of China

Xiao Shuai, MD, Juan Xu, MD, Xushu Zhong, MD, Yan Li, MD, Wenjiao Tang, MD, Huanling Zhu, MD, Ting Niu, MD& PhD, Yu Wu, MD& PhD, Yongqian Jia, MD, Xu Cui, MD, Ling Pan, MD& PhD, Hong Chang, MD, Yuping Gong, MD& PhD, Bing Xiang, MD, Jie Huang, MD, Jianjun Li, MD, Chuan He, MD, Xinchuan Chen, MD, Liping Xie, MD& PhD, Hongbing Ma, MD, Jie Ji, MD, Yang Dai, MD & PhD, Zhigang Liu, MD, Ting Liu, MD & PhD
Journal: Blood
Blood (2016) 128 (22): 4882.
https://doi.org/10.1182/blood.V128.22.4882.4882
Published: 2016